PharmacyFlow
Compounding Pharmacy Software503A Pharmacy Software503B Outsourcing FacilityGLP-1 FulfillmentFulfillment Automation (WES)
PlatformDirectoryPricingPartners
Log InDemoRequest a Demo
All suppliersBy drugCompounding pharmaciesManufacturers
P
PharmacyFlow

The AI operating system for modern pharmacies. One platform. Every step. Better outcomes.

Directory
  • All suppliers
  • Who makes what
  • Compounding pharmacies
  • Manufacturers
Platform
  • Compounding Pharmacy Software
  • 503A Pharmacy Software
  • 503B Outsourcing Facility
  • GLP-1 Fulfillment
Company
  • Who We Are
  • Pricing
  • Security
  • Request a Demo

Listings are compiled from public records — the NPPES national provider registry and the FDA National Drug Code Directory. Pharmacy Flow does not verify unclaimed listings and publishes no pricing for them.

Is a listing wrong, or would you like it removed? Tell us — we action corrections and removal requests.

© 2026 Pharmacy Flow. All rights reserved.
Directory/Sanofi Vaccines US Inc.

Sanofi Vaccines US Inc.

Drug manufacturer · manufacturer

Unclaimed listing
Request a quoteClaim this listing
24
Drug products
4
Therapeutic areas

About

Sanofi Vaccines US Inc. is listed in the FDA National Drug Code Directory with 24 marketed products, of which 3 are prescription drugs. Dosage forms include INJECTION, KIT.

What Sanofi Vaccines US Inc. makes

8 of 24 products
Clear
Prescription · 3
Biologics & Vaccines · 10Injectable & Infusion · 8Other · 5Nutrition & Supplements · 1
injection · 20kit · 4
  • FLUBLOK TRIVALENT NORTHERN HEMISPHERE
    influenza a virus a/missouri/11/2025 (h1n1) recombinant hemagglutinin antigen, influenza a virus a/darwin/1415/2025 (h3n2) recombinant hemagglutinin antigen, and influenza b virus b/pennsylvania/14/2025 recombinant hemagglutinin antigen
    QuoteinjectionintramuscularBLA
  • FLUZONE HIGH DOSE NORTHERN HEMISPHERE
    influenza a virus a/switzerland/6849/2025 ivr-278 (a/missouri/11/2025 pdm09-like virus) (h1n1) antigen (formaldehyde inactivated), influenza a virus a/michigan/105/2025 san-049a (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated)
    Quoteinjection, suspensionintramuscularBLA
  • FLUZONE TRIVALENT NORTHERN HEMISPHERE
    influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/michigan/105/2025 san-049a (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated)
    Quoteinjection, suspensionintramuscularBLA
  • FLUZONE TRIVALENT NORTHERN HEMISPHERE
    influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/michigan/105/2025 san-049a (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated)
    Quoteinjection, suspensionintramuscularBLA
  • FLUZONE HD TIV SH 2026
    influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/gp20238/2024 ivr-277 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated)
    Quoteinjection, suspensionintramuscularBLA
  • FLUZONE TIV SH 2026
    influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/gp20238/2024 ivr-277 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated)
    Quoteinjection, suspensionintramuscularBLA
  • FLUZONE TIV SH 2026
    influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/gp20238/2024 ivr-277 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated)
    Quoteinjection, suspensionintramuscularBLA
  • MenQuadfi
    neisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide tetanus toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide tetanus toxoid conjugate antigen
    Quoteinjection, solutionintramuscularBLA

Get a price

This listing is unclaimed, so post your requirement and every verified pharmacy licensed in your state will bid.

Request a quote

Contact

Email and website are not published in the public registries — they are added when the listing is claimed.

From the FDA NDC Directory, refreshed 2026-08-15.

Is this your business?

Claim the listing to publish your catalog, answer buyer enquiries and bid on sourcing requests.

Claim this listing